| Market Cap | 38.25B | P/E | 11.39 | EPS this Y | - | Ern Qtrly Grth | 3.90% |
| Income | 500.45B | Forward P/E | 5.61 | EPS next Y | - | 50D Avg Chg | -3.00% |
| Sales | 3.02T | PEG | - | EPS past 5Y | - | 200D Avg Chg | 4.00% |
| Dividend | 1,917.00% | Price/Book | 0.01 | EPS next 5Y | 5.10% | 52W High Chg | -7.00% |
| Recommedations | 4.00 | Quick Ratio | 1.01 | Shares Outstanding | 3.55B | 52W Low Chg | 36.00% |
| Insider Own | - | ROA | 5.59% | Shares Float | 1.06B | Beta | 0.32 |
| Inst Own | 0.01% | ROE | 11.89% | Shares Shorted/Prior | -/- | Price | 10.71 |
| Gross Margin | 55.46% | Profit Margin | 16.58% | Avg. Volume | 50,025 | Target Price | 11.00 |
| Oper. Margin | 25.91% | Earnings Date | Oct 31 | Volume | 40,326 | Change | -0.83% |
Japan Tobacco Inc., a tobacco company, manufactures and sells tobacco products, pharmaceuticals, and processed foods in Japan and internationally. The company operates through three segments: Tobacco Business, Pharmaceutical Business, and Processed Food Business. It offers tobacco products, such as cigarettes, heat-not-burn tobacco products, E-vapor products, fine cut tobacco products, cigars, pipes, smokeless tobacco products, and hookah and kretek products. The company provides reduced-risk products, including infused tobacco capsules and heated tobacco sticks. In addition, it researches and develops, manufactures, and sells prescription drugs for the therapeutic areas, such as cardiovascular, kidney and metabolism, immunity/inflammation, and central nervous system. Further, the company provides frozen and room-temperature products, such as frozen udon noodles, packed rice, and frozen okonomiyaki; bakery products; and seasonings, including yeast extracts, assembled, kelp and bonito extracts, and oyster sauces. It offers its products under the Winston, Camel, MEVIUS, and LD brands. Japan Tobacco Inc. was incorporated in 1985 and is headquartered in Tokyo, Japan.